COMP <GO>
BCPC vs HXL // RSI-14 & 200D SMA MOMENTUM
Balchem Corporation (NASDAQ) VS. Hexcel Corporation (NYSE) • 15-METRIC TALLY: BCPC 11
— HXL 2
▲ RSI-14 & 200D SMA MOMENTUM LEADER: BCPC
LAST: $170.40 (+2.47%) • MKT CAP: $5.41B
rsi-technicals
50.4
LAST: $79.55 (+1.97%) • MKT CAP: $6.02B
rsi-technicals
36.9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BCPC VS. HXL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BCPC | HXL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.70% | 23.00% | +12.70 | BCPC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.00% | 6.20% | +7.80 | BCPC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.5x | 29.7x | -4.20 | BCPC | /valuation <GO> |
| Free Cash Flow Yield | 4.00% | 2.61% | +1.39 | BCPC | /fcf-yield <GO> |
| Operating Margin | 20.20% | 9.10% | +11.10 | BCPC | /operating-margins <GO> |
| Net Profit Margin | 14.90% | 5.80% | +9.10 | BCPC | /net-margins <GO> |
| Revenue Growth (YoY) | 8.80% | -0.50% | +9.30 | BCPC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.52% | 0.90% | -0.38 | HXL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.67 | 4.77 | +4.90 | BCPC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | BCPC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 50.4 | 36.9 | +13.53 | BCPC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.02 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.6x | 51.2x | -18.60 | BCPC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.41B | $6.02B | -$607.2M | HXL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BCPC REV | HXL REV | BCPC GROSS % | HXL GROSS % | BCPC FCF | HXL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.04B | $1.89B | 35.7% | 23.0% | $216.6M | $157.2M |
| FY 2024 | $953.7M | $1.90B | 35.3% | 24.7% | $182.0M | $202.9M |
| FY 2023 | $922.4M | $1.79B | — | — | $183.8M | $176.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BCPC // BETA —
HXL // BETA 1.02